Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Autor: Paediatric IBD Porto Group of ESPGHAN, Joosse, M E, Aardoom, M A, Kemos, P, Turner, D, Wilson, D C, Koletzko, S, Martin-de-Carpi, J, Fagerberg, U L, Spray, C, Tzivinikos, C, Sladek, M, Shaoul, R, Roma-Giannikou, E, Bronsky, J, Serban, D E, Ruemmele, F M, Garnier-Lengline, H, Veres, G, Hojsak, I, Kolho, K L, Davies, I H, Aloi, M, Lionetti, P, Hussey, S, Veereman, G, Braegger, C P, Trindade, E, Wewer, A V, Hauer, A C, de Vries, A C H, Sigall Boneh, R, Sarbagili Shabat, C, Levine, A, de Ridder, L

Publikováno v: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Alimentary Pharmacology & Therapeutics, 48(5), 523-537. Wiley-Blackwell Publishing Ltd

Background: Risk benefit strategies in managing inflammatory bowel diseases (IBD) are dependent upon understanding the risks of uncontrolled inflammation vs those of treatments. Malignancy and mortality in IBD have been associated with disease-relate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a334ca65bb9a1aa30e5472a381e5ff57
https://doi.org/10.1111/apt.14893

Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Autor: Joosse, M. E. Aardoom, M. A. Kemos, P. Turner, D. and Wilson, D. C. Koletzko, S. Martin-de-Carpi, J. Fagerberg, U. L. Spray, C. Tzivinikos, C. Sladek, M. Shaoul, R. and Roma-Giannikou, E. Bronsky, J. Serban, D. E. Ruemmele, F. M. and Garnier-Lengline, H. Veres, G. Hojsak, I. Kolho, K. L. and Davies, I. H. Aloi, M. Lionetti, P. Hussey, S. and Veereman, G. Braegger, C. P. Trindade, E. Wewer, A. V. and Hauer, A. C. de Vries, A. C. H. Boneh, R. Sigall Shabat, C. Sarbagili Levine, A. de Ridder, L. Paediat IBD Porto Grp ESPGHAN

Background: Risk benefit strategies in managing inflammatory bowel diseases (IBD) are dependent upon understanding the risks of uncontrolled inflammation vs those of treatments. Malignancy and mortality in IBD have been associated with disease-relate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cfc3cf51bef8ead6c6d48706841ff661
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3181301

The effect of inflammation severity and of treatment on the production and release of TNFα by colonic explants in inflammatory bowel disease.

Autor: Dionne, S.^1,2 (AUTHOR), Ruemmele, F. M.^1,3 (AUTHOR), Laberge, S.^1,2 (AUTHOR), Seidman, E. G.^1,2,3 (AUTHOR)

Publikováno v: Alimentary Pharmacology & Therapeutics. Nov2000, Vol. 14 Issue 11, p1435-1442. 8p.

Diagnostic approach and management of cow's milk protein allergy in infants and children:A practical guideline of the GI-committee of ESPGHAN

Autor: Koletzko, S, Niggemann, B, Arato, A, Dias, J A, Heuschkel, R, Husby, S, Mearin, M L, Papadopoulou, Aikaterini, Ruemmele, F M, Staiano, A, Schäppi, M G, Vandenplas, Y

Publikováno v: Koletzko, S, Niggemann, B, Arato, A, Dias, J A, Heuschkel, R, Husby, S, Mearin, M L, Papadopoulou, A, Ruemmele, F M, Staiano, A, Schäppi, M G & Vandenplas, Y 2012, ' Diagnostic approach and management of cow's milk protein allergy in infants and children : A practical guideline of the GI-committee of ESPGHAN ', Journal of Pediatric Gastroenterology and Nutrition, vol. 55, no. 2, pp. 221-9 . https://doi.org/10.1097/MPG.0b013e31825c9482

OBJECTIVES:: This position paper provides recommendations for the diagnosis and management of suspected cow's milk protein allergy (CMPA) in Europe. It presents a practical approach with a diagnostic algorithm and is based on recently published evide

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::a30e605a4a6e46c81f2c680a2e3d3199
https://portal.findresearcher.sdu.dk/da/publications/f59363c7-8714-416f-b2e8-eff369866027

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.